Estamos trabajando para incorporar este artículo al repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor


Chronic use of methamphetamine (METH) leads to long-lasting cognitive dysfunction in humans and in animal models. Modafinil is a wake-promoting compound approved for the treatment of sleeping disorders. It is also prescribed off label to treat METH dependence. In the present study, we investigated whether modafinil could improve cognitive deficits induced by sub-chronic METH treatment in mice by measuring visual retention in a Novel Object Recognition (NOR) task. After sub-chronic METH treatment (1 mg/kg, once a day for 7 days), mice performed the NOR task, which consisted of habituation to the object recognition arena (5 min a day, 3 consecutive days), training session (2 equal objects, 10 min, day 4), and a retention session (1 novel object, 5 min, day 5). One hour before the training session, mice were given a single dose of modafinil (30 or 90 mg/kg). METH-treated mice showed impairments in visual memory retention, evidenced by equal preference of familiar and novel objects during the retention session. The lower dose of modafinil (30 mg/kg) had no effect on visual retention scores in METH-treated mice, while the higher dose (90 mg/kg) rescued visual memory retention to control values. We also measured extracellular signal-regulated kinase (ERK) phosphorylation in medial prefrontal cortex (mPFC), hippocampus, and nucleus accumbens (NAc) of METH- and vehicle-treated mice that received modafinil 1 h before exposure to novel objects in the training session, compared to mice placed in the arena without objects. Elevated ERK phosphorylation was found in the mPFC of vehicle-treated mice, but not in METH-treated mice, exposed to objects. The lower dose of modafinil had no effect on ERK phosphorylation in METH-treated mice, while 90 mg/kg modafinil treatment restored the ERK phosphorylation induced by novelty in METH-treated mice to values comparable to controls. We found neither a novelty nor treatment effect on ERK phosphorylation in hippocampus or NAc of vehicle- and METH-treated mice receiving acute 90 mg/kg modafinil treatment. Our results showed a palliative role of modafinil against METH-induced visual cognitive impairments, possibly by normalizing ERK signaling pathways in mPFC. Modafinil may be a valuable pharmacological tool for the treatment of cognitive deficits observed in human METH abusers as well as in other neuropsychiatric conditions. This article is part of the Special Issue entitled 'CNS Stimulants'. © 2014 Elsevier Ltd.


Documento: Artículo
Título:Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice
Autor:González, B.; Raineri, M.; Cadet, J.L.; García-Rill, E.; Urbano, F.J.; Bisagno, V.
Filiación:Instituto de Investigaciones Farmacológicas, Ciudad Autónoma de Buenos Aires, Junín 956, Piso 5, Buenos Aires, C1113, Argentina
Laboratorio de Fisiología y Biología Molecular, Instituto de Fisiología, Biología Molecular y Neurociencias, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Molecular Neuropsychiatry Research Branch, NIH/NIDA Intramural Research Program, Baltimore, MD, United States
Center for Translational Neuroscience, Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, United States
Palabras clave:ERK; Methamphetamine; Modafinil; Novelty; Prefrontal cortex; methamphetamine; mitogen activated protein kinase 1; mitogen activated protein kinase 3; modafinil; benzhydryl derivative; central stimulant agent; methamphetamine; mitogen activated protein kinase; modafinil; nootropic agent; animal experiment; animal model; Article; cognitive defect; controlled study; dose response; enzyme phosphorylation; exploratory behavior; habituation; hippocampus; male; medial prefrontal cortex; memory disorder; mouse; nonhuman; novel object recognition test; nucleus accumbens; palliative therapy; prefrontal cortex; signal transduction; single drug dose; visual memory; animal; C57BL mouse; chemically induced; drug effects; Memory Disorders; metabolism; motor activity; neuropsychological test; pathophysiology; phosphorylation; physiology; recognition; vision; withdrawal syndrome; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Exploratory Behavior; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Male; MAP Kinase Signaling System; Memory Disorders; Methamphetamine; Mice, Inbred C57BL; Motor Activity; Neuropsychological Tests; Nootropic Agents; Nucleus Accumbens; Phosphorylation; Prefrontal Cortex; Recognition (Psychology); Substance Withdrawal Syndrome; Visual Perception
Página de inicio:188
Página de fin:197
Título revista:Neuropharmacology
Título revista abreviado:Neuropharmacology
CAS:methamphetamine, 28297-73-6, 51-57-0, 537-46-2, 7632-10-2; mitogen activated protein kinase 1, 137632-08-7; mitogen activated protein kinase 3, 137632-07-6; modafinil, 68693-11-8; mitogen activated protein kinase, 142243-02-5; Benzhydryl Compounds; Central Nervous System Stimulants; Extracellular Signal-Regulated MAP Kinases; Methamphetamine; modafinil; Nootropic Agents


  • Antunes, M., Biala, G., The novel object recognition memory: Neurobiology, test procedure, and its modifications (2012) Cogn. Process., 13 (2), pp. 93-110
  • Bamford, N.S., Zhang, H., Joyce, J.A., Scarlis, C.A., Hanan, W., Wu, N.P., André, V.M., Sulzer, D., Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration (2008) Neuron, 58 (1), pp. 89-103
  • Barker, G.R., Warburton, E.C., When is the hippocampus involved in recognition memory? (2011) J. Neurosci., 31 (29), pp. 10721-10731
  • Bevins, R.A., Besheer, J., Palmatier, M.I., Jensen, H.C., Pickett, K.S., Eurek, S., Novel-object place conditioning: Behavioral and dopaminergic processes in expression of novelty reward (2002) Behav. Brain Res., 129 (12), pp. 41-50
  • Bisagno, V., Ferguson, D., Luine, V.N., Short toxic methamphetamine schedule impairs object recognition task in male rats (2002) Brain Res., 940 (12), pp. 95-101
  • Cammarota, M., Bevilaqua, L.R., Medina, J.H., Izquierdo, I., ERK1/2 and CaMKII-mediated events in memory formation: Is 5HT regulation involved? (2008) Behav. Brain Res., 195 (1), pp. 120-128
  • Dackis, C.A., Kampman, K.M., Lynch, K.G., Pettinati, H.M., O'Brien, C.P., A double-blind, placebo-controlled trial of modafinil for cocaine dependence (2005) Neuropsychopharmacology, 30 (1), pp. 205-211
  • Dackis, C.A., Kampman, K.M., Lynch, K.G., Plebani, J.G., Pettinati, H.M., Sparkman, T., O'Brien, C.P., A double-blind, placebo-controlled trial of modafinil for cocaine dependence (2012) J. Subst. Abuse Treat., 43 (3), pp. 303-312
  • De Saint Hilaire, Z., Orosco, M., Rouch, C., Blanc, G., Nicolaidis, S., Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: A microdialysis study in rats (2001) Neuroreport, 12 (16), pp. 3533-3537
  • Dopheide, M.M., Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants (2007) Eur. J. Pharmacol., 568 (13), pp. 112-123
  • Ennaceur, A., One-trial object recognition in rats and mice: Methodological and theoretical issues (2010) Behav. Brain Res., 215 (2), pp. 244-254
  • Feltenstein, M.W., See, R.E., The neurocircuitry of addiction: An overview (2008) Br. J. Pharmacol., 154, pp. 261-274
  • Finke, K., Dodds, C.M., Bublak, P., Regenthal, R., Baumann, F., Manly, T., Müller, U., Effects of modafinil and methylphenidate on visual attention capacity: A TVA-based study (2010) Psychopharmacology (Berl), 210 (3), pp. 317-329
  • Forwood, S.E., Winters, B.D., Bussey, T.J., Hippocampal lesions that abolish spatial maze performance spare object recognition memory at delays of up to 48 hours (2005) Hippocampus, 15 (3), pp. 347-355
  • Garcia, V.A., Souza De Freitas, B., Busato, S.B., D'Avila Portal, B.C., Piazza, F.C., Schröder, N., Differential effects of modafinil on memory in naïve and memory-impaired rats (2013) Neuropharmacology, 75 C, pp. 304-311
  • Garcia-Rill, E., Heister, D.S., Ye, M., Charlesworth, A., Hayar, A., Electrical coupling: Novel mechanism for sleep-wake control (2007) Sleep, 30 (11), pp. 1405-1414
  • Ghahremani, D.G., Tabibnia, G., Monterosso, J., Hellemann, G., Poldrack, R.A., London, E.D., Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals (2011) Neuropsychopharmacology, 36 (5), pp. 950-959
  • Gozzi, A., Colavito, V., Seke Etet, P.F., Montanari, D., Fiorini, S., Tambalo, S., Bifone, A., Bentivoglio, M., Modulation of fronto-cortical activity by modafinil: A functional imaging and fos study in the rat (2012) Neuropsychopharmacology, 37 (3), pp. 822-837
  • Heinzerling, K.G., Swanson, A.N., Kim, S., Cederblom, L., Moe, A., Ling, W., Shoptaw, S., Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence (2010) Drug Alcohol Depend., 109 (13), pp. 20-29
  • Herin, D.V., Rush, C.R., Grabowski, J., Agonist-like pharmacotherapy for stimulant dependence: Preclinical, human laboratory, and clinical studies (2010) Ann. N. Y. Acad. Sci., 1187, pp. 76-100
  • Hester, R., Lee, N., Pennay, A., Nielsen, S., Ferris, J., The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence (2010) Exp. Clin. Psychopharmacol., 18 (6), pp. 489-497
  • Kalechstein, A.D., De La Garza, R., II, Newton, T.F., Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment (2010) Am. J. Addict., 19 (4), pp. 340-344
  • Kalechstein, A.D., Mahoney, J.J., III, Yoon, J.H., Bennett, R., De La Garza, R., II, Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users (2013) Neuropharmacology, 64, pp. 472-478
  • Kamei, H., Nagai, T., Nakano, H., Togan, Y., Takayanagi, M., Takahashi, K., Kobayashi, K., Yamada, K., Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK activation in the prefrontal cortex of mice (2006) Biol. Psychiatry, 59 (1), pp. 75-84
  • Kauer, J.A., Malenka, R.C., Synaptic plasticity and addiction (2007) Nat. Rev. Neurosci., 8, pp. 844-858
  • Kelly, A., Laroche, S., Davis, S., Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase in hippocampal circuitry is required for consolidation and reconsolidation of recognition memory (2003) J. Neurosci., 23 (12), pp. 5354-5360
  • McGaugh, J., Mancino, M.J., Feldman, Z., Chopra, M.P., Gentry, W.B., Cargile, C., Oliveto, A., Open-label pilot study of modafinil for methamphetamine dependence (2009) J. Clin. Psychopharmacol., 29 (5), pp. 488-491
  • Mele, A., Avena, M., Roullet, P., De Leonibus, E., Mandillo, S., Sargolini, F., Coccurello, R., Oliverio, A., Nucleus accumbens dopamine receptors in the consolidation of spatial memory (2004) Behav. Pharmacol., 15 (56), pp. 423-431
  • Mereu, M., Bonci, A., Newman, A.H., Tanda, G., The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders (2013) Psychopharmacology, 229 (3), pp. 415-434
  • Minzenberg, M.J., Carter, C.S., Modafinil: A review of neurochemical actions and effects on cognition (2008) Neuropsychopharmacology, 33 (7), pp. 1477-1502
  • Mizoguchi, H., Yamada, K., Mizuno, M., Mizuno, T., Nitta, A., Noda, Y., Nabeshima, T., Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors (2004) Mol. Pharmacol., 65 (5), pp. 1293-1301
  • Monterosso, J.R., Aron, A.R., Cordova, X., Xu, J., London, E.D., Deficits in response inhibition associated with chronic methamphetamine abuse (2005) Drug. Alcohol Depend., 79 (2), pp. 273-277
  • Morgan, E.E., Woods, S.P., Poquette, A.J., Vigil, O., Heaton, R.K., Grant, I., Visual memory in methamphetamine-dependent individuals: Deficient strategic control of encoding and retrieval (2012) Aust. N. Z. J. Psychiatry, 46 (2), pp. 141-152
  • Nagai, T., Takuma, K., Kamei, H., Ito, Y., Nakamichi, N., Ibi, D., Nakanishi, Y., Yamada, K., Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex (2007) Learn. Mem., 14 (3), pp. 117-125
  • Nelson, A.J., Thur, K.E., Marsden, C.A., Cassaday, H.J., Dissociable roles of dopamine within the core and medial shell of the nucleus accumbens in memory for objects and place (2010) Behav. Neurosci., 124 (6), pp. 789-799
  • Nguyen, T.L., Tian, Y.H., You, I.J., Lee, S.Y., Jang, C.G., Modafinil-induced conditioned place preference via dopaminergic system in mice (2011) Synapse, 65 (8), pp. 733-741
  • Nordahl, T.E., Salo, R., Leamon, M., Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review (2003) J. Neuropsychiatry Clin. Neurosci., 15 (3), pp. 317-325
  • Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Toru, M., Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET (1997) Nature, 385 (6617), pp. 634-636
  • Paulus, M.P., Hozack, N.E., Zauscher, B.E., Frank, L., Brown, G.G., Braff, D.L., Schuckit, M.A., Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects (2002) Neuropsychopharmacology, 26 (1), pp. 53-63
  • Raineri, M., Gonzalez, B., Goitia, B., Garcia-Rill, E., Krasnova, I.N., Cadet, J.L., Urbano, F.J., Bisagno, V., Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum (2012) PLoS One, 7 (10), p. 46599
  • Raineri, M., Peskin, V., Goitia, B., Taravini, I.R., Giorgeri, S., Urbano, F.J., Bisagno, V., Attenuated methamphetamine induced neurotoxicity by modafinil administration in mice (2011) Synapse, 65 (10), pp. 1087-1098
  • Redrobe, J.P., Bull, S., Plath, N., Translational aspects of the novel object recognition task in rats abstinent following sub-sub-chronic treatment with phencyclidine (PCP): Effects of modafinil and relevance to cognitive deficits in schizophrenia (2010) Front. Psychiatry, 1, p. 146
  • Reichel, C.M., Schwendt, M., McGinty, J.F., Olive, M.F., See, R.E., Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5 (2011) Neuropsychopharmacology, 36 (4), pp. 782-792
  • Robinson, T.E., Berridge, K.C., The neural basis of drug craving: An incentive-sensitization theory of addiction (1993) Brain Res. Brain Res. Rev., 18 (3), pp. 247-291
  • Robinson, T.E., Kolb, B., Structural plasticity associated with exposure to drugs of abuse (2004) Neuropharmacology, 47 (SUPPLEMENT 1), pp. 33-46
  • Sargolini, F., Roullet, P., Oliverio, A., Mele, A., Effects of intra-accumbens focal administrations of glutamate antagonists on object recognition memory in mice (2003) Behav. Brain Res., 138 (2), pp. 153-163
  • Schmaal, L., Joos, L., Koeleman, M., Veltman, D.J., Van Den Brink, W., Goudriaan, A.E., Effects of modafinil on neural correlates of response inhibition in alcohol-dependent patients (2013) Biol. Psychiatry, 73 (3), pp. 211-218
  • Schoenbaum, G., Shaham, Y., The role of orbitofrontal cortex in drug addiction: A review of preclinical studies (2008) Biol. Psychiatry, 63 (3), pp. 256-262
  • Scoriels, L., Jones, P.B., Sahakian, B.J., Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain (2013) Neuropharmacology, 64, pp. 168-184
  • Scott, J.C., Woods, S.P., Matt, G.E., Meyer, R.A., Heaton, R.K., Atkinson, J.H., Grant, I., Neurocognitive effects of methamphetamine: A critical review and meta-analysis (2007) Neuropsychol. Rev., 17 (3), pp. 275-297
  • Shearer, J., Darke, S., Rodgers, C., Slade, T., Van Beek, I., Lewis, J., Brady, D., Wodak, A., A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence (2009) Addiction, 104 (2), pp. 224-233
  • Simon, S.L., Dean, A.C., Cordova, X., Monterosso, J.R., London, E.D., Methamphetamine dependence and neuropsychological functioning: Evaluating change during early abstinence (2010) J. Stud. Alcohol Drugs, 71 (3), pp. 335-344
  • Soeiro Ada, C., Moreira, K.D., Abrahao, K.P., Quadros, I.M., Oliveira, M.G., Individual differences are critical in determining modafinil-induced behavioral sensitization and cross-sensitization with methamphetamine in mice (2012) Behav. Brain Res., 233 (2), pp. 367-374
  • Tritsch, N.X., Sabatini, B.L., Dopaminergic modulation of synaptic transmission in cortex and striatum (2012) Neuron, 76 (1), pp. 33-50
  • Urbano, F.J., Leznik, E., Llinás, R.R., Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling (2007) Proc. Natl. Acad. Sci. U. S. A., 104 (30), pp. 12554-12559
  • Valjent, E., Corvol, J.C., Pages, C., Besson, M.J., Maldonado, R., Caboche, J., Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties (2000) J. Neurosci., 20 (23), pp. 8701-8709
  • Valjent, E., Pagès, C., Hervé, D., Girault, J.A., Caboche, J., Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain (2004) Eur. J. Neurosci., 19 (7), pp. 1826-1836
  • Vocci, F.J., Appel, N.M., Approaches to the development of medications for the treatment of methamphetamine dependence (2007) Addiction, 102 (SUPPLEMENT 1), pp. 96-106
  • Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Franceschi, D., Sedler, M., Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications (2009) JAMA: J. Am. Med. Assoc., 301 (11), pp. 1148-1154
  • Young, J.W., Geyer, M.A., Action of modafinil-increased motivation via the dopamine transporter inhibition and D1 receptors? (2010) Biol. Psychiatry, 67 (8), pp. 784-787
  • Young, J.W., Kooistra, K., Geyer, M.A., Dopamine receptor mediation of the exploratory/hyperactivity effects of modafinil (2011) Neuropsychopharmacology, 36 (7), pp. 1385-1396
  • Zack, M., Poulos, C.X., Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs.Low impulsivity (2009) J. Psychopharmacol., 23 (6), pp. 660-671
  • Zanassi, P., Paolillo, M., Feliciello, A., Avvedimento, E.V., Gallo, V., Schinelli, S., CAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons (2001) J. Biol. Chem., 276 (15), pp. 11487-11495
  • Zhai, H., Li, Y., Wang, X., Lu, L., Drug-induced alterations in the extracellular signal-regulated kinase (ERK) signalling pathway: Implications for reinforcement and reinstatement (2008) Cell. Mol. Neurobiol., 28 (2), pp. 157-172


---------- APA ----------
González, B., Raineri, M., Cadet, J.L., García-Rill, E., Urbano, F.J. & Bisagno, V. (2014) . Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice. Neuropharmacology, 87, 188-197.
---------- CHICAGO ----------
González, B., Raineri, M., Cadet, J.L., García-Rill, E., Urbano, F.J., Bisagno, V. "Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice" . Neuropharmacology 87 (2014) : 188-197.
---------- MLA ----------
González, B., Raineri, M., Cadet, J.L., García-Rill, E., Urbano, F.J., Bisagno, V. "Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice" . Neuropharmacology, vol. 87, 2014, pp. 188-197.
---------- VANCOUVER ----------
González, B., Raineri, M., Cadet, J.L., García-Rill, E., Urbano, F.J., Bisagno, V. Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice. Neuropharmacology. 2014;87:188-197.